KERRI ANN GREY

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family GANSEVOORT, NY NPI 1699400747

General Payments — all program years on this page

$1,135.41

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 49
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $598.46 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $598.4621

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2022 $32.542
2023 $504.4126
2024 $598.4621

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078426437 Janssen Biotech, Inc. $20.45 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100291398 Novo Nordisk Inc $15.58 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100318946 Novo Nordisk Inc $16.39 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100386273 Novo Nordisk Inc $88.24 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104369111 AstraZeneca Pharmaceuticals LP $10.02 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104428537 AstraZeneca Pharmaceuticals LP $17.80 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105327176 AstraZeneca Pharmaceuticals LP $125.00 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107253991 ABBVIE INC. $25.44 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107253993 ABBVIE INC. $33.28 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114423661 Exact Sciences Corporation $27.41 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116164719 GlaxoSmithKline, LLC. $17.89 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116241479 GlaxoSmithKline, LLC. $14.19 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116251996 GlaxoSmithKline, LLC. $15.56 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119084508 Otsuka America Pharmaceutical, Inc. $25.41 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119084510 Otsuka America Pharmaceutical, Inc. $24.73 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131706454 PFIZER INC. $17.20 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131718401 PFIZER INC. $14.20 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132001179 PFIZER INC. $20.52 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132031790 PFIZER INC. $21.16 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135748698 Lilly USA, LLC $22.39 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135760672 Lilly USA, LLC $25.60 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.